Purchase Order HHSN275201600278P

The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Molecular Devices LLC on September 14, 2020, for an ID3 multi-mode microplate detection platform at a ceiling value of $25,000.00. Place of performance is San Jose, California. The order was issued under firm fixed-price terms with an ultimate completion date of September 30, 2020. The procurement was not set-aside and originated from a pre-solicitation opportunity posted on September 13, 2020.

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for $24,545.41 on August 10, 2016. The order procures various laboratory equipment on a firm fixed price basis. Place of performance is Carlsbad, California. The order is scheduled for completion by September 30, 2016.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation on September 15, 2016, for various laboratory supplies with a firm fixed price of $6,684.06. Performance will occur in Grand Island, New York. The order carries an ultimate completion date of September 19, 2017.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $7,701 purchase order to Molecular Devices LLC for maintenance services. As a division of Danaher Corporation, Molecular Devices LLC will provide maintenance contract services at its place of performance in Bethesda, Maryland through November 2017. This firm fixed price order was awarded under the HHS-NIH contract vehicle to support the agency's...

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for $8,880.15 on August 9, 2016. Work was performed in Carlsbad, California. The order was firm fixed price with an ultimate completion date of January 31, 2021. No set-aside was used.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $12,061.94 on November 20, 2019 for instrument relocation services. Place of performance is San Diego, California. The order, issued as a firm fixed-price purchase order with no set-aside designation, de-obligates expired contract lines. The ultimate completion date is December 31, 2019.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $7,882.56 on March 29, 2016. The order is firm fixed price with no set-aside designation. Place of performance is San Diego, California. The order expired on April 24, 2016. No further details regarding the specific items or services procured are provided in the source material.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Molecular Devices LLC for a SpectraMax ID3 multi-mode microplate detection platform on September 21, 2020, with a ceiling value of $30,343.10. Performance occurs in San Jose, California. The order is firm fixed price with an ultimate completion date of October 20, 2020. The opportunity was posted as a pre-solicitation on September 3, 2020, with a due date of September 8, 2020.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $17,525.75 on March 2, 2016, for on-site field service engineer labor supporting reinstallation work. The order carries a firm fixed price and concludes January 31, 2021. Work is performed in San Diego, California.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $81,885.40 on June 22, 2018, with ultimate completion on December 21, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order was a firm fixed price acquisition for scientific instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio supporting research and diagnostic missions.</p>